WO1995025554A1 - Two-component device for the administration of drugs - Google Patents

Two-component device for the administration of drugs Download PDF

Info

Publication number
WO1995025554A1
WO1995025554A1 PCT/EP1995/001003 EP9501003W WO9525554A1 WO 1995025554 A1 WO1995025554 A1 WO 1995025554A1 EP 9501003 W EP9501003 W EP 9501003W WO 9525554 A1 WO9525554 A1 WO 9525554A1
Authority
WO
WIPO (PCT)
Prior art keywords
plunger
coupling
container
administration
stopper
Prior art date
Application number
PCT/EP1995/001003
Other languages
French (fr)
Inventor
Roberto Bigagli
Gianni Grillenzoni
Mauro Landi
Augusto Arcari
Original Assignee
Bracco S.P.A.
Dibra S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco S.P.A., Dibra S.P.A. filed Critical Bracco S.P.A.
Priority to JP52437295A priority Critical patent/JP3614856B2/en
Priority to AU21091/95A priority patent/AU2109195A/en
Priority to DE29580137U priority patent/DE29580137U1/en
Priority to GB9619020A priority patent/GB2301537B/en
Publication of WO1995025554A1 publication Critical patent/WO1995025554A1/en
Priority to NO963990A priority patent/NO963990L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/24Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
    • A61M5/2422Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic using emptying means to expel or eject media, e.g. pistons, deformation of the ampoule, or telescoping of the ampoule
    • A61M5/2429Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic using emptying means to expel or eject media, e.g. pistons, deformation of the ampoule, or telescoping of the ampoule by telescoping of ampoules or carpules with the syringe body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/3129Syringe barrels

Definitions

  • This invention refers to a device for the administration of aqueous solutions or suspensions of drugs or diagnostic agents including, for instance, contrast media for X-ray, magnetic resonance and ultrasound procedures.
  • this invention refers to a two-component device, substantially constituted by: a) a piston-container, which is prefilled with an injectable solution/suspension, and sealed by a stopper-plunger, b) a housing-barrel, provided with collecting and administration systems. Said components a) and b) are combined together only when used, ensuring the preparation sterility.
  • Figure 3 details the structure of the group responsible for the strong coupling of said housing-barrel with said piston-container, that's to say the stopper-plunger; the same Figure 3 shows as a matter of example, a possible stopper- gasket ensuring the external sealing of the piston-container; - Figure 4 shows the elements assembled in the position of use.
  • the housing-barrel (1) (Fig. 2) is preferably made of plastic for medical or pharmaceutical uses. This material which has to sustain, without deformation or damages, the commonly used sterilization conditions (for instance autoclave) can also be made of totally or nearly totally biodegradable material (in any case said housing-barrel (1) can also be made of glass). It generally has a tubular structure and is substantially constituted by an external jacket (2) and an inner jacket (3). Said jackets (2) and (3) define an annular cavity (4) closed at one end by a pierced sealing (5) to which an external joint formation (6) is applied for the connection, for instance, of a hypodermic needle (not drawn in the figures).
  • Said sealing (5) can also be provided with another inner joint unit (7), to which the inner jacket (3) is connected in case said inner jacket (3) has to be removed after the use, to recover the part of the housing-barrel which did not come into contact with the administered liquid.
  • said removal is feasible thanks to suitable side openings (8) in the external jacket (2) (as from Figures 2 and 4, shaded parts), which allow an easy access to the inside of the housing-barrel (1).
  • a needle (9) is housed, which extends for the entire housing-barrel (1) length and ends, opened end (10), with a sharp tip (11). Said sharp tip (11) must not protrude from (1) and therefore must be in line (or preferably slightly inside) with respect to the opened extremity (10).
  • the needle (9) is preferably made of steel, but plastic needles can be equally used, with obvious benefits from the environmental and economical point of view, when biodegradable plastic is used.
  • the external jacket (2) is equipped with an external flange (12) acting as handle for the use of the device.
  • the needle (9) is surrounded by a coupling group (13) (Fig. 2 circular shaded part), responsible for the connection and the coupling to the stopper-plunger of the piston-container.
  • the coupling group (13) is bell shaped and made of the same material of the inner jacket (3), forming a unique block with the same.
  • the other element of the device that's to say the piston-container (14) (Fig. 1) is preferably constituted by a cylindrical body (15) closed at one end, made of glass or plastic for pharmaceutical use, which contains the drug or the contrast medium solution/suspension to be injected (19).
  • Said container (15) is sealed at the mouth by a mobile device (16) (stopper-plunger), acting as a sealing element, and as a plunger able to slide inside the container (15).
  • the stopper-plunger (16) is preferably made of soft rubber (for instance bromobuthyl, chlorobuthyl rubber or analogous mixtures), or of other elastomeric materials (possibly even autolubricating) . In any case it is designed to ensure an excellent sliding inside the container (15), supplying at the same time a perfect sealing, during the sterilization phase of the packaging, the stocking period and also during the use.
  • the piston-container (14) is sealed with a suitable and tightly sealing gasket (17).
  • Said gasket (17) can be fixed in different ways, for instance with easily removable blocking capsules (which are not shown in the figures), for instance flip-off capsules. Of course these devices require for instance suitable possibilities of seaming (18) to the container mouth (15), which should be accordingly designed.
  • the stopper-plunger (16) is crossed by an axial hole (20) closed by a diaphragm (21) which will be perforated by the sharp tip of the needle (9).
  • a cavity (22) is housed whose shape is complementary to the coupling group (13) of the inner jacket (3) of the housing-barrel (1).
  • Said cavity (22), as for Fig. 4 is responsible for the coupling of the two components of the device of this invention. These two components are usually packaged as sterile assembling kit ready for the use.
  • the stopper-gasket (17) is removed by releasing the blocking and sealing systems associated to it (which are not illustrated). Then the piston-container (14) is connected to the opened end (10) of syringe (1) following the conditions of Figure 4, that's to say the introduction of the peripheral wall of the container (14) into the annular cavity (4) defined by the jackets (2) and (3) of the barrel (1).
  • This result can be achieved by connecting the stopper-plunger (16) to the end (13) of the inner jacket (3) and by favouring the introduction of said end (13) into the cavity (22) in order to accomplish a shape coupling between the two parts.
  • a hypodermic needle can be, for instance, inserted on the handle (6) and, after having seized the flange (12) of the syringe (1) with two fingers, the pressure of the thumb on the container (15) base allows the introduction of the same inside the annular cavity (4) of the housing-barrel (1) with the consequent retraction of the plunger (16) into the container (15). This produces the outflow of the liquid content (19) through the needle (9) and therefore through the hypodermic needle placed on the handle (6).
  • the firm coupling of the stopper-plunger (16) to the coupling device (13) as previously described allows in any case the possible retraction of the container (15), when necessary, for instance during an injection.
  • the type of material constituting the stopper-plunger (16) allows an excellent sealing action in the connection between container (15) and needle (9). All these characteristics do not dampen the sliding capacity of the stopper-plunger (16), favouring a remarkably smooth performance of the administration procedure.

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)

Abstract

This invention refers to a device for the administration of aqueous solutions or suspensions of drugs or diagnostic agents including, for instance, contrast media for x-ray, magnetic resonance and ultra-sound procedures. In particular this invention refers to a two-component device, substantially constituted by: a) a piston-container (14), which is prefilled with an injectable solution/suspension (19), and sealed by a stopper-plunger (16), b) a housing-barrel (1), provided with collecting (11) and administration system (9). Said components a) and b) are combined together only when used, ensuring the preparation sterility. The two components (14, 1) are joined by bell-shaped male coupling (13) with a sharp needle (11) connectable to a complementarily shaped cavity (22) in the stopper-plunger (16).

Description

TWO-COMPONENT DEVICE FOR THE ADMINISTRATION OF DRUGS
This invention refers to a device for the administration of aqueous solutions or suspensions of drugs or diagnostic agents including, for instance, contrast media for X-ray, magnetic resonance and ultrasound procedures. In particular this invention refers to a two-component device, substantially constituted by: a) a piston-container, which is prefilled with an injectable solution/suspension, and sealed by a stopper-plunger, b) a housing-barrel, provided with collecting and administration systems. Said components a) and b) are combined together only when used, ensuring the preparation sterility.
Devices apparently comparable to that of this invention are known in the state of the art. Among the most interesting documents we can cite for instance those reported in the following documents: WO 9218178, EP-A 0206971, US 3994296, FR-A 2262535, DE-U 9003505, FR-A 1551012.
Nevertheless none of them succeeded in solving the most important problems related to this kind of device, such as for instance:
1) a perfect sealing of the stopper-plunger, ensuring a good sliding capacity;
2) a perfect coupling system of the two components which is both simple (for instance the screw type is excluded) and efficient in order to allow the possible sliding back of the piston-container during the use, when needed;
3) the need of avoiding that the sharp end of the housing-barrel collecting system (the collecting needle tip) accidentally comes into contact with the operator.
In particular WO 9218178, which suggests one of the simplest and most interesting solution, was not able to solve points 1) and 2) in an acceptable way.
The object of this invention is going to be described as a non-limiting example, with reference to the annexed drawings (Figures 1-4), wherein: - Figures 1 and 2 are axial sections of the two elements constituting the claimed device (piston- container and housing-barrel),
Figure 3 details the structure of the group responsible for the strong coupling of said housing-barrel with said piston-container, that's to say the stopper-plunger; the same Figure 3 shows as a matter of example, a possible stopper- gasket ensuring the external sealing of the piston-container; - Figure 4 shows the elements assembled in the position of use.
The housing-barrel (1) (Fig. 2) is preferably made of plastic for medical or pharmaceutical uses. This material which has to sustain, without deformation or damages, the commonly used sterilization conditions (for instance autoclave) can also be made of totally or nearly totally biodegradable material (in any case said housing-barrel (1) can also be made of glass). It generally has a tubular structure and is substantially constituted by an external jacket (2) and an inner jacket (3). Said jackets (2) and (3) define an annular cavity (4) closed at one end by a pierced sealing (5) to which an external joint formation (6) is applied for the connection, for instance, of a hypodermic needle (not drawn in the figures). Said sealing (5) can also be provided with another inner joint unit (7), to which the inner jacket (3) is connected in case said inner jacket (3) has to be removed after the use, to recover the part of the housing-barrel which did not come into contact with the administered liquid. In this case, said removal is feasible thanks to suitable side openings (8) in the external jacket (2) (as from Figures 2 and 4, shaded parts), which allow an easy access to the inside of the housing-barrel (1).
Inside the inner jacket (3), preferably in central axial position, a needle (9) is housed, which extends for the entire housing-barrel (1) length and ends, opened end (10), with a sharp tip (11). Said sharp tip (11) must not protrude from (1) and therefore must be in line (or preferably slightly inside) with respect to the opened extremity (10). The needle (9) is preferably made of steel, but plastic needles can be equally used, with obvious benefits from the environmental and economical point of view, when biodegradable plastic is used. At its opened end (10), the external jacket (2), is equipped with an external flange (12) acting as handle for the use of the device.
Through the pierce in the sealing (5), is directly connected with the external joint (6). At the opposed end (opened end (10)) the needle (9) is surrounded by a coupling group (13) (Fig. 2 circular shaded part), responsible for the connection and the coupling to the stopper-plunger of the piston-container. The coupling group (13) is bell shaped and made of the same material of the inner jacket (3), forming a unique block with the same.
The other element of the device, that's to say the piston-container (14) (Fig. 1) is preferably constituted by a cylindrical body (15) closed at one end, made of glass or plastic for pharmaceutical use, which contains the drug or the contrast medium solution/suspension to be injected (19). Said container (15) is sealed at the mouth by a mobile device (16) (stopper-plunger), acting as a sealing element, and as a plunger able to slide inside the container (15). The stopper-plunger (16) is preferably made of soft rubber (for instance bromobuthyl, chlorobuthyl rubber or analogous mixtures), or of other elastomeric materials (possibly even autolubricating) . In any case it is designed to ensure an excellent sliding inside the container (15), supplying at the same time a perfect sealing, during the sterilization phase of the packaging, the stocking period and also during the use.
After the filling with the desired pharmaceutical composition and the sealing with the stopper-plunger (16) (this operation is preferably carried out under slight depression), the piston-container (14) is sealed with a suitable and tightly sealing gasket (17). Said gasket (17) can be fixed in different ways, for instance with easily removable blocking capsules (which are not shown in the figures), for instance flip-off capsules. Of course these devices require for instance suitable possibilities of seaming (18) to the container mouth (15), which should be accordingly designed.
The stopper-plunger (16) is crossed by an axial hole (20) closed by a diaphragm (21) which will be perforated by the sharp tip of the needle (9).
The most remarkable feature of the solution according of this invention is that in the upper part of the stopper-plunger (16), that's to say the external one, a cavity (22) is housed whose shape is complementary to the coupling group (13) of the inner jacket (3) of the housing-barrel (1). Said cavity (22), as for Fig. 4, is responsible for the coupling of the two components of the device of this invention. These two components are usually packaged as sterile assembling kit ready for the use.
During the use the stopper-gasket (17) is removed by releasing the blocking and sealing systems associated to it (which are not illustrated). Then the piston-container (14) is connected to the opened end (10) of syringe (1) following the conditions of Figure 4, that's to say the introduction of the peripheral wall of the container (14) into the annular cavity (4) defined by the jackets (2) and (3) of the barrel (1). This result can be achieved by connecting the stopper-plunger (16) to the end (13) of the inner jacket (3) and by favouring the introduction of said end (13) into the cavity (22) in order to accomplish a shape coupling between the two parts. This result is generally achieved due to the penetration and the snapping shut of the bell-shaped coupling group (13) (male part) inside the complementary cavity (22) (female part). This performance is easily carried out thanks to the general softness of the plunger (16) material; in fact the locking lip (23) which defines the narrow part of the cavity mouth (22) appears to be elastically yielding with respect to the action of penetration of the coupling group (13). On the other hand, the inner/inferior shape of said lip (23) has been designed to firmly block the coupling group (13) once the penetration has been accomplished, avoiding an easy release of the group with a consequent release of the two parts.
In this way an automatic snapping shut coupling operation with a precise coupling ratio of complementary shape can be performed, as shown in Figure 4.
Due to this coupling, the needle (9), in particular its sharp tip (11), cracks the diaphragm (21) so that the inner cavity of the piston-container (14) comes into contact with the inside of the collecting needle (9).
Now, a hypodermic needle can be, for instance, inserted on the handle (6) and, after having seized the flange (12) of the syringe (1) with two fingers, the pressure of the thumb on the container (15) base allows the introduction of the same inside the annular cavity (4) of the housing-barrel (1) with the consequent retraction of the plunger (16) into the container (15). This produces the outflow of the liquid content (19) through the needle (9) and therefore through the hypodermic needle placed on the handle (6).
The firm coupling of the stopper-plunger (16) to the coupling device (13) as previously described allows in any case the possible retraction of the container (15), when necessary, for instance during an injection. In addition the type of material constituting the stopper-plunger (16) allows an excellent sealing action in the connection between container (15) and needle (9). All these characteristics do not dampen the sliding capacity of the stopper-plunger (16), favouring a remarkably smooth performance of the administration procedure.
Finally, we must not discard the environmental impact. The possible use of biodegradable materials, as well as the possibility of a easily removable inner jacket (3) after the use, and the reuse of the same external container syringe for a high number of procedures, highly contribute to a production decrease of waste in the field of disposable injectable products.

Claims

3 CLAIMS
1. A device for the administration of aqueous solutions/suspensions of drugs and/or diagnostic agents comprising a first element (14) and a second element
(1), to be coupled one to the other when used, wherein: the first element (14) comprises a container for fluids (15), sealed by a stopper-plunger (16), which can be opened to the flow of a fluid through a pierceble baffle (21) and which can slide inside said container (15), in order to produce the outlet of the fluid contained in it, the second element (1) is a housing-barrel comprising a inner jacket (3), equipped with collecting (11) and administration systems (9) said jacket (3) being joinable to the plunger (16), piercing it in (21) and allowing its motion inside the container (15), producing the outlet of the fluid contained in it, - the jacket (3) and the plunger (16), are respectively associated to complementary shapes of male (13) and female (22) coupling systems, which perform a mutual strong coupling when said first and the second element, (14) and (1) respectively, are combined together so that the container (15) can be retracted during the use, said collecting and administration systems connected to (3) comprise a needle (9) ending with a sharp tip (11), to pierce the plunger (16) through the baffle (21), being said tip (11) surrounded by the male coupling device (13) and protruded with respect to the same, and in addition, said coupling device (13) and said sharp tip (11) are housed inside the barrel (1) slightly retracted with respect to the opened end (10) of the same, in order to avoid any contact with the operator, further being, said male coupling device (13), bell-shaped, while the corresponding complementary female part (22) of the plunger (16) is provided with a locking lip (23) specifically designed to favour the coupling of said parts (13) and (22), to firmly block said coupling and avoid an easy release thereof.
2. A device according to claim 1 characterized by the fact that: said inner jacket (3) of element (1) is removably fixed in the inside (7) of the sealing (5) of said element (1), thus allowing the after-use recovery and the re-use of that part of (1) which does not come into contact with the administered fluid, and in addition, the external jacket (2) of said element (1) is provided with side openings (8), designed for allowing a smooth access in the interior of (1) to remove said inner jacket (3).
3. A device according to claim 1 or 2 wherein the first (14) and the second element (1) are cylindrically shaped and the complementary coupling parts (13) and (22) are generally placed in axial position with respect to said elements (14) and (1).
4. A device according to any of the previous claims wherein: the collecting and administration needle (9) is made of steel, or plastic, the stopper-plunger (16) is made of elastomeric material, such as bromo- or chlorobutyl rubber or similar mixtures, granting high sealing and sliding performances, the other parts constituting the elements (14) and (1) can be made of glass, or plastic, or some of glass and some of plastic, being generally (14) made of glass and (1) of plastic, wherein the plastic material selected to sustain without deformation or damages the sterilization conditions used and in addition . it can also be totally or partially biodegradable.
5. A device according to any of the previous claims for the administration of contrast media formulations for X-ray, magnetic resonance and ultrasound diagnostic procedures.
PCT/EP1995/001003 1994-03-24 1995-03-17 Two-component device for the administration of drugs WO1995025554A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP52437295A JP3614856B2 (en) 1994-03-24 1995-03-17 2-element dosing device
AU21091/95A AU2109195A (en) 1994-03-24 1995-03-17 Two-component device for the administration of drugs
DE29580137U DE29580137U1 (en) 1994-03-24 1995-03-17 Two-part device for the administration of drugs
GB9619020A GB2301537B (en) 1994-03-24 1995-03-17 Two-component device for the administration of drugs
NO963990A NO963990L (en) 1994-03-24 1996-09-23 Two-component device for drug delivery

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT94MI000221U IT233201Y1 (en) 1994-03-24 1994-03-24 TWO-COMPONENT DEVICE FOR THE ADMINISTRATION OF DRUGS
ITMI94U000221 1994-03-24

Publications (1)

Publication Number Publication Date
WO1995025554A1 true WO1995025554A1 (en) 1995-09-28

Family

ID=11367796

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1995/001003 WO1995025554A1 (en) 1994-03-24 1995-03-17 Two-component device for the administration of drugs

Country Status (9)

Country Link
US (1) US5520642A (en)
JP (1) JP3614856B2 (en)
AU (1) AU2109195A (en)
CH (1) CH691031A5 (en)
DE (1) DE29580137U1 (en)
GB (1) GB2301537B (en)
IT (1) IT233201Y1 (en)
NO (1) NO963990L (en)
WO (1) WO1995025554A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6486174B2 (en) 2000-08-07 2002-11-26 3-Dimensional Pharmaceuticals, Inc. Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9111049D0 (en) * 1991-05-22 1991-07-17 Parkin Adrian Hypodermic needle
DK0902694T3 (en) * 1995-08-22 2003-07-28 Mdc Invest Holdings Inc Pre-filled injection cartridge with retractable needle
US6123688A (en) * 1995-08-22 2000-09-26 Mdc Investment Holdings, Inc. Pre-filled retractable needle injection devices
US7300416B2 (en) 1995-08-22 2007-11-27 Specialized Health Products International Pre-filled retractable needle injection ampoules
US9289618B1 (en) 1996-01-08 2016-03-22 Impulse Dynamics Nv Electrical muscle controller
US8321013B2 (en) 1996-01-08 2012-11-27 Impulse Dynamics, N.V. Electrical muscle controller and pacing with hemodynamic enhancement
DE69732774T2 (en) * 1996-01-08 2006-02-02 Impulse Dynamics N.V. Device for controlling cardiac activity using non-excitatory pre-stimulation
US7167748B2 (en) * 1996-01-08 2007-01-23 Impulse Dynamics Nv Electrical muscle controller
US8825152B2 (en) 1996-01-08 2014-09-02 Impulse Dynamics, N.V. Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue
US9713723B2 (en) 1996-01-11 2017-07-25 Impulse Dynamics Nv Signal delivery through the right ventricular septum
AU720748B2 (en) 1996-04-22 2000-06-08 Abbott Laboratories Container closure system
US5954104A (en) 1997-02-28 1999-09-21 Abbott Laboratories Container cap assembly having an enclosed penetrator
US5924584A (en) * 1997-02-28 1999-07-20 Abbott Laboratories Container closure with a frangible seal and a connector for a fluid transfer device
US6569115B1 (en) * 1997-08-28 2003-05-27 Mdc Investment Holdings, Inc. Pre-filled retractable needle injection device
US6039713A (en) * 1997-08-28 2000-03-21 Mdc Investment Holdings, Inc. Pre-filled retractable needle injection device
US6003566A (en) 1998-02-26 1999-12-21 Becton Dickinson And Company Vial transferset and method
US6681946B1 (en) 1998-02-26 2004-01-27 Becton, Dickinson And Company Resealable medical transfer set
US6382442B1 (en) 1998-04-20 2002-05-07 Becton Dickinson And Company Plastic closure for vials and other medical containers
US6378714B1 (en) 1998-04-20 2002-04-30 Becton Dickinson And Company Transferset for vials and other medical containers
US6904662B2 (en) * 1998-04-20 2005-06-14 Becton, Dickinson And Company Method of sealing a cartridge or other medical container with a plastic closure
US6209738B1 (en) 1998-04-20 2001-04-03 Becton, Dickinson And Company Transfer set for vials and medical containers
US6957745B2 (en) * 1998-04-20 2005-10-25 Becton, Dickinson And Company Transfer set
NZ513303A (en) * 1999-02-04 2003-03-28 Technion Res & Dev Foundation Three dimensional plug flow bioreactor, and its use for the maintenance and expansion of hemopoietic stem cells and/or progenitor cells
FR2789890B1 (en) * 1999-02-22 2002-01-18 Lab Contactologie Appl Lca DEVICE FOR INJECTING AN INTRAOCULAR LENS IN FLEXIBLE MATERIAL
US8019421B2 (en) 1999-03-05 2011-09-13 Metacure Limited Blood glucose level control
US9101765B2 (en) 1999-03-05 2015-08-11 Metacure Limited Non-immediate effects of therapy
US8700161B2 (en) 1999-03-05 2014-04-15 Metacure Limited Blood glucose level control
US8666495B2 (en) 1999-03-05 2014-03-04 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
WO2006073671A1 (en) 2004-12-09 2006-07-13 Impulse Dynamics Nv Protein activity modification
US8346363B2 (en) 1999-03-05 2013-01-01 Metacure Limited Blood glucose level control
US6993385B1 (en) * 1999-10-25 2006-01-31 Impulse Dynamics N.V. Cardiac contractility modulation device having anti-arrhythmic capabilities and a method of operating thereof
WO2001030445A1 (en) 1999-10-25 2001-05-03 Impulse Dynamics N.V. Cardiac contractility modulation device having anti-arrhythmic capabilities and a method of operating thereof
US7027863B1 (en) 1999-10-25 2006-04-11 Impulse Dynamics N.V. Device for cardiac therapy
DE60227245D1 (en) * 2001-03-13 2008-08-07 Mdc Invest Holdings Inc PRE-FILLED SAFETY DILUENT INJECTOR
US20040186428A1 (en) * 2002-09-11 2004-09-23 Utpal Ray Auto-destructible syringe
DE602004027705D1 (en) * 2003-02-10 2010-07-29 N trig ltd TOUCH DETECTION FOR A DIGITIZER
US11439815B2 (en) 2003-03-10 2022-09-13 Impulse Dynamics Nv Protein activity modification
JP2006519663A (en) 2003-03-10 2006-08-31 インパルス ダイナミックス エヌヴイ Apparatus and method for delivering electrical signals for regulating gene expression in heart tissue
US8792985B2 (en) 2003-07-21 2014-07-29 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US8352031B2 (en) 2004-03-10 2013-01-08 Impulse Dynamics Nv Protein activity modification
US11779768B2 (en) 2004-03-10 2023-10-10 Impulse Dynamics Nv Protein activity modification
GB2418616A (en) * 2004-10-04 2006-04-05 Dewan Fazlul Hoque Chowdhury Injection device with a piston having needle and plunger attachments.
US9821158B2 (en) 2005-02-17 2017-11-21 Metacure Limited Non-immediate effects of therapy
WO2006097934A2 (en) 2005-03-18 2006-09-21 Metacure Limited Pancreas lead
EP1898991B1 (en) 2005-05-04 2016-06-29 Impulse Dynamics NV Protein activity modification
US8934975B2 (en) 2010-02-01 2015-01-13 Metacure Limited Gastrointestinal electrical therapy
US20120046411A1 (en) 2010-08-20 2012-02-23 Becton, Dickinson And Company Recycled Resin Compositions And Disposable Medical Devices Made Therefrom
USD667107S1 (en) 2011-11-04 2012-09-11 Becton, Dickinson And Company Syringe plunger rod
USD673268S1 (en) 2011-11-04 2012-12-25 Becton, Dickinson And Company Syringe plunger rod
USD673675S1 (en) 2011-11-04 2013-01-01 Becton, Dickinson And Company Syringe plunger rod
USD667109S1 (en) 2011-11-04 2012-09-11 Becton, Dickinson And Company Syringe plunger rod
US20130116628A1 (en) 2011-11-04 2013-05-09 Becton, Dickinson And Company Recycled Resin Compositions And Disposable Medical Devices Made Therefrom
USD713028S1 (en) 2011-11-04 2014-09-09 Becton, Dickinson And Company Syringe plunger rod
USD667108S1 (en) 2011-11-04 2012-09-11 Becton, Dickinson And Company Syringe plunger rod

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1817003A (en) * 1924-04-26 1931-08-04 George N Hein Hypodermic syringe
US1848711A (en) * 1932-03-08 Hypodermic sybinckb
US3916894A (en) * 1972-09-20 1975-11-04 Nosco Plastics Syringe seals and piston
FR2300578A1 (en) * 1975-02-13 1976-09-10 Illinois Tool Works MEDICINE INJECTION DEVICE
EP0206971A1 (en) * 1985-05-29 1986-12-30 VECTA GLASS COMPANY Ltd. Syringe for direct use
WO1992018178A1 (en) * 1991-04-18 1992-10-29 Tecnomedica Ricerche S.R.L. Device for the administration of drugs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4014330A (en) * 1975-10-28 1977-03-29 Abbott Laboratories Disposable two-compartment syringe
IT223172Z2 (en) * 1991-04-09 1995-06-13 Tecnomedica Ricerche Srl DEVICE FOR THE ADMINISTRATION OF DRUGS, PARTICULARLY TWO-COMPONENT PHARMA-CI

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1848711A (en) * 1932-03-08 Hypodermic sybinckb
US1817003A (en) * 1924-04-26 1931-08-04 George N Hein Hypodermic syringe
US3916894A (en) * 1972-09-20 1975-11-04 Nosco Plastics Syringe seals and piston
FR2300578A1 (en) * 1975-02-13 1976-09-10 Illinois Tool Works MEDICINE INJECTION DEVICE
EP0206971A1 (en) * 1985-05-29 1986-12-30 VECTA GLASS COMPANY Ltd. Syringe for direct use
WO1992018178A1 (en) * 1991-04-18 1992-10-29 Tecnomedica Ricerche S.R.L. Device for the administration of drugs

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6486174B2 (en) 2000-08-07 2002-11-26 3-Dimensional Pharmaceuticals, Inc. Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists

Also Published As

Publication number Publication date
JPH09510380A (en) 1997-10-21
NO963990D0 (en) 1996-09-23
GB2301537A (en) 1996-12-11
CH691031A5 (en) 2001-04-12
NO963990L (en) 1996-11-14
GB2301537B (en) 1998-02-25
US5520642A (en) 1996-05-28
ITMI940221U1 (en) 1995-09-24
DE29580137U1 (en) 1997-02-06
JP3614856B2 (en) 2005-01-26
ITMI940221V0 (en) 1994-03-24
AU2109195A (en) 1995-10-09
GB9619020D0 (en) 1996-10-23
IT233201Y1 (en) 2000-01-26

Similar Documents

Publication Publication Date Title
US5520642A (en) Two-component device for the administration of drugs
RU2678791C2 (en) Syringe with rolling diaphragm
KR101124390B1 (en) Flush syringe having anti-reflux features
US4927423A (en) Connector and a disposable assembly utilizing said connector
JP4112009B2 (en) Adapter and nozzle for syringe loading
US6280418B1 (en) Container for storing and dispensing injection, infusion and diagnostic preparations
CN100444909C (en) Single-use syringe
KR100273834B1 (en) Medical valve
EP0704225B1 (en) Retractable needle syringe
JP4698838B2 (en) Retractable needle syringe
EP3345640B1 (en) Positive displacement flush syringe
US6840291B2 (en) Attachment for a medical device
US7387615B2 (en) Single use syringe having safety shield
EP1773433A1 (en) Non-skin penetrating reconstituting syringe
JPS59118164A (en) Subcateneous syringe
KR101124387B1 (en) Flush syringe having anti-reflux stopper
JPH0380029B2 (en)
JP2015521528A (en) Clip syringe
CA2167787C (en) Non-reusable syringe
JP4498618B2 (en) Needle retractable syringe
JP4103127B2 (en) Mixing container
JP3759244B2 (en) Syringe
JP7295859B2 (en) Low-cost syringe with durable and disposable components
JPH069673Y2 (en) Drug enema
CA3194790A1 (en) Closing element for a fluid line

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AT AT AU BG CA CH CN CZ CZ DE DE DK DK ES FI FI GB HU JP KR LU NL NO NZ PL PT RO RU SE UA

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase